ACHC September 18th Options Begin Trading

The note presents option strategies for Acadia Healthcare (ACHC) with the stock trading at $11.80: a sell-to-open $7.50 put (bid $0.25) yields a net cost basis of $7.25, is ~36% out-of-the-money, has an 84% probability to expire worthless and a 3.33% return (4.95% annualized) if it does. A covered call at the $15.00 strike (bid $0.40) would cap upside to $15.00 but deliver a 30.51% total return to expiry (Sept. 18) and shows a 49% chance to expire worthless, producing a 3.39% yield boost (5.03% annualized). Implied vols are elevated (put 115%, call 83%) versus trailing 12-month volatility of 62%, and StockOptionsChannel will track odds and contract history over time.

Analysis

Market structure: Option sellers and disciplined cash-rich buyers are the immediate beneficiaries — cash-secured put sellers can target a $7.25 effective entry (25¢ premium) vs spot $11.80, while call sellers can boost carry ~3.4% into Sep 18. The pronounced put-call IV skew (puts 115% vs calls 83% vs realized 62%) signals asymmetric perceived downside risk for ACHC and elevates cost-of-hedge across the small-cap behavioral-health niche, pressuring volatility-sensitive funding lines and potentially widening ACHC credit spreads if equity stress materializes.

Risk assessment: Tail risks include adverse Medicaid/Medicare reimbursement policy changes, regulatory probes into patient placement, or a surprise earnings miss that forces guided write-downs — each could erase >40% of equity value in weeks. Near-term (days–weeks) risk is option gamma/IV decay into Sep 18; medium-term (months) hinges on Q3 revenue and payer cadence; long-term (quarters–years) outcome depends on reimbursement recovery and consolidation risk from private equity buyers.

Trade implications: Tactical trades should exploit rich put IV and skew: favor selling cash-secured Sep 18 $7.50 puts sized to be assignable (target 0.5–2% portfolio exposure) or implement a bear-put vertical to cap tail risk. For equity holders, buy-write (long ACHC + sell Sep 18 $15 calls) captures ~30% capped upside to Sep 18 while generating 5% annualized carry; hedge sector beta by shorting UHS (Universal Health Services, UHS) to isolate ACHC-specific volatility.

Contrarian angles: The market is likely overpricing downside relative to realized volatility — puts trade ~85% chance to expire worthless per analytics — creating a short-volatility edge if you can absorb assignment. Conversely, consensus may underappreciate operational/regulatory binary risks (M&A or investigations) that could gap price; therefore use defined-risk credit spreads or small position sizes until 1–2 post-earnings prints validate direction.

Key Decisions for Investors

• Sell cash‑secured Sep 18 ACHC $7.50 puts size equal to desired 1% portfolio allocation (obligates $7.25 effective entry); collect $0.25 now but close or roll if ACHC < $7.00 or IV compresses >30% — target R/R: max assignment cost $7.50, yield 3.33% on cash until Sep 18.
• Establish a buy‑write: buy ACHC at market (~$11.80) and sell Sep 18 $15 calls to lock ~30.5% upside to strike; position size 1–2% notional, delta-hedge with -0.4x UHS (short UHS) to neutralize broad hospital beta until post‑earnings (60 days).
• If worried about tail risk, sell Sep 18 ACHC $7.50 put and buy Sep 18 $6.00 put (bull put spread) to cap downside; target net credit ≈ current premium minus protection cost, max loss = strike width less credit, exit if ACHC > $9.50 or IV drops >35%.
• Monitor three catalysts over next 60 days before scaling: (1) next ACHC earnings release — miss >5% EPS consensus → reduce long size; (2) Medicaid/Medicare policy announcements — any unfavorable guidance → widen stop to -35%; (3) IV contraction >40% → harvest short-vol strategies and lock profits.